Hepatology Clinical Guidelines
Advert for Healthcare Professionals only
Mannitol dry powder for inhalation for treating cystic fibrosis
Nov 2012Mannitol (Bronchitol, Pharmaxis) is a mucoactive agent that causes water to enter the airway lumen and hydrate airway..
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Aug 2012CC is the second commonest primary liver tumour worldwide, after hepatocellular carcinoma (HCC). These guidelines are..
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
Jun 2012Alcoholic liver disease (ALD) is the most prevalent cause of advanced liver disease in Europe. However, there has been..
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
Apr 2012Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential for therapy of the..
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
Apr 2012EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular carcinoma (HCC) define the use of..
Erratum to: "EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma"
Apr 2012Fig. 3 was incomplete for BCLC stage A, and it has been corrected as per below. Patients at BCLC stage A and single..
EASL Clinical Practice Guidelines: Wilson’s disease
Feb 2012This Clinical Practice Guideline (CPG) has been developed to assist physicians and other healthcare providers in the..
Guidelines for Liver Transplantation for Patients with Non-Alcoholic Steatohepatitis
Jan 2012Non-alcoholic steatohepatitis (NASH) is an increasing cause of liver disease necessitating liver transplantation. In..
Guidelines for the Management of Autoimmune Hepatitis
May 2011These guidelines describe the optimal management strategies in adults based on available published evidence, including..
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection - updated June 2011
Mar 2011These EASL Clinical Practice Guidelines (CPGs) are intended to assist physicians and other healthcare providers, as well..
Alcohol-use disorders: Diagnosis, assessment and management of harmful drinking and alcohol dependence
Feb 2011This guideline makes recommendations on the diagnosis, assessment and management of harmful drinking and alcohol..
Neurological problems in liver transplantation
Jan 2011The recommendation section includes statements classifi ed in levels A – C derived from Classes I – III of evidence..
Neurological problems in liver transplantation
Jan 2011The recommendation section includes statements classifi ed in levels A – C derived from Classes I – III of evidence..
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
Sep 2010This guidance should be read in conjunction with the following NICE guidance: • NICE technology appraisal guidance 75..
Alcohol use disorders: diagnosis and clinical management of alcohol-related physical complications
Jan 2010The care of adults and young people (aged 10 years and older) who have any health problems that are completely or partly..
Entecavir for the treatment of chronic hepatitis B
Sep 2008Entecavir, within its marketing authorisation, is recommended as an option for the treatment of people with chronic..
Telbivudine for the treatment of chronic hepatitis B
Aug 2008This guidance does not apply to people with chronic hepatitis B who also have hepatitis C, hepatitis D or HIV...
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B
Feb 2007NICE has made the following recommendations about the use of adefovir dipivoxil and peginterferon alfa-2a to treat..
Advert for Healthcare Professionals only